81 FR 12496 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 81, Issue 46 (March 9, 2016)

Page Range		12496-12496
FR Document		2016-05267

Federal Register, Volume 81 Issue 46 (Wednesday, March 9, 2016)

[Federal Register Volume 81, Number 46 (Wednesday, March 9, 2016)]
[Notices]
[Page 12496]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-05267]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding Opportunity Announcement (FOA), DP 
16-002, Michigan Lupus Epidemiology and Surveillance (MILES) Program 
Longitudinal Cohort Study.
    Time and Date: 11:00 a.m.-6:00 p.m., EDT, April 5, 2016 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``FOA DP16-002, Michigan Lupus Epidemiology and Surveillance (MILES) 
Program Longitudinal Cohort Study''.
    Contact Person for More Information: Jaya Raman Ph.D., Scientific 
Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, 
Georgia 30341, Telephone: (770) 488-6511, [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2016-05267 Filed 3-8-16; 8:45 am]
BILLING CODE 4163-18-P

12496 Federal Register / Vol. 81, No. 46 / Wednesday, March 9, 2016 / Notices

Leroy A. Richardson, Prevention and the Agency for Toxic DEPARTMENT OF HEALTH AND
Chief, Information Collection Review Office, Substances and Disease Registry. HUMAN SERVICES
Office of Scientific Integrity, Office of the
Catherine Ramadei,
Associate Director for Science, Office of the Centers for Disease Control and
Director, Centers for Disease Control and Acting Director, Management Analysis and
Services Office, Centers for Disease Control Prevention
Prevention.
and Prevention.
[FR Doc. 2016–05235 Filed 3–8–16; 8:45 am] Board of Scientific Counselors, Office
[FR Doc. 2016–05266 Filed 3–8–16; 8:45 am]
BILLING CODE 4163–18–P of Infectious Diseases (BSC, OID)
BILLING CODE 4163–18–P

In accordance with section 10(a)(2) of
DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND the Federal Advisory Committee Act
HUMAN SERVICES HUMAN SERVICES (Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
Centers for Disease Control and Centers for Disease Control and announces the following meeting of the
Prevention Prevention aforementioned committee:
Disease, Disability, and Injury Disease, Disability, and Injury Time and Date: 2:00–4:00 p.m., EDT,
Prevention and Control Special Prevention and Control Special March 28, 2016.
Emphasis Panel (SEP): Initial Review Emphasis Panel (SEP): Initial Review Place: Teleconference.
In accordance with Section 10(a)(2) of Status: The meeting is open to the
In accordance with Section 10(a)(2) of public; the toll free dial in number is 1–
the Federal Advisory Committee Act
the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease 877–951–7311 with a pass code of
(Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) 7972741.
Control and Prevention (CDC) announces a meeting for the initial Purpose: The BSC, OID, provides
announces a meeting for the initial review of applications in response to advice and guidance to the Secretary,
review of applications in response to Funding Opportunity Announcement Department of Health and Human
Funding Opportunity Announcement (FOA), DP 16–002, Michigan Lupus Services; the Director, CDC; the
(FOA) DD 16–001, Centers for Autism Epidemiology and Surveillance (MILES) Director, OID; and the Directors of the
and Developmental Disabilities Program Longitudinal Cohort Study.
Time and Date: 11:00 a.m.–6:00 p.m., National Center for Immunization and
Research and Epidemiology (CADDRE):
EDT, April 5, 2016 (Closed). Respiratory Diseases, the National
Study to Explore Early Development
Place: Teleconference. Center for Emerging and Zoonotic
(SEED) 3.
Status: The meeting will be closed to Infectious Diseases, and the National
Time and Date: 10:00 a.m.–6:00 p.m., the public in accordance with Center for HIV/AIDS, Viral Hepatitis,
EDT, April 7, 2016 (Closed). provisions set forth in Section STD, and TB Prevention, CDC, in the
Place: Teleconference. 552b(c)(4) and (6), Title 5 U.S.C., and following areas: Strategies, goals, and
Status: The meeting will be closed to the Determination of the Director, priorities for programs; research within
the public in accordance with Management Analysis and Services the national centers; and overall
provisions set forth in Section Office, CDC, pursuant to Public Law 92– strategic direction and focus of OID and
463. the national centers.
552b(c)(4) and (6), Title 5 U.S.C., and Matters for Discussion: The meeting
the determination of the Director, will include the initial review, Matters for Discussion: Topics to be
Management Analysis and Services discussion, and evaluation of discussed during the teleconference
Office, CDC, pursuant to Public Law 92– applications received in response to include administrative/budget issues,
463. ‘‘FOA DP16–002, Michigan Lupus current emerging infectious disease
Matters for Discussion: The meeting Epidemiology and Surveillance (MILES) outbreak responses, and reports from
will include the initial review, Program Longitudinal Cohort Study’’. recent program meetings.
discussion, and evaluation of Contact Person for More Information: The agenda and any supplemental
applications received in response to Jaya Raman Ph.D., Scientific Review material will be available at
‘‘FOA DD16–001, Centers for Autism Officer, CDC, 4770 Buford Highway, www.cdc.gov/oid/BSC/
and Developmental Disabilities Mailstop F80, Atlanta, Georgia 30341, meetingschedule.html after March 20.
Research and Epidemiology (CADDRE): Telephone: (770) 488–6511, kva5@
cdc.gov. Agenda items are subject to change as
Study to Explore Early Development priorities dictate.
The Director, Management Analysis
(SEED) 3’’. and Services Office, has been delegated Contact Person for More Information:
Contact Person for More Information: the authority to sign Federal Register Robin Moseley, M.A.T., Designated
Jaya Raman Ph.D., Scientific Review notices pertaining to announcements of Federal Officer, OID, CDC, 1600 Clifton
Officer, CDC, 4770 Buford Highway, meetings and other committee Road NE., Mailstop D10, Atlanta,
Mailstop F80, Atlanta, Georgia 30341, management activities, for both the Georgia 30333, Telephone: (404) 639–
Telephone: (770) 488–6511, kva5@ Centers for Disease Control and 4461.
cdc.gov. Prevention and the Agency for Toxic
Substances and Disease Registry. The Director, Management Analysis
Lhorne on DSK5TPTVN1PROD with NOTICES

The Director, Management Analysis and Services Office has been delegated
and Services Office, has been delegated Catherine Ramadei, the authority to sign Federal Register
the authority to sign Federal Register Acting Director, Management Analysis and notices pertaining to announcements of
notices pertaining to announcements of Services Office, Centers for Disease Control meetings and other committee
meetings and other committee and Prevention.
management activities, for both the
management activities, for both the [FR Doc. 2016–05267 Filed 3–8–16; 8:45 am]
Centers for Disease Control and
Centers for Disease Control and BILLING CODE 4163–18–P

VerDate Sep<11>2014 15:08 Mar 08, 2016 Jkt 238001 PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 E:\FR\FM\09MRN1.SGM 09MRN1

Document Created: 2016-03-09 00:13:54
Document Modified: 2016-03-09 00:13:54

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		11:00 a.m.-6:00 p.m., EDT, April 5, 2016 (Closed).
FR Citation		81 FR 12496

81 FR 12496 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 81, Issue 46 (March 9, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention